← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2012Last known activity
Apr 1, 2023
Timeline
1990s
- Jun 1, 1992
Inmunotek S.L.— Founded
Drugs by trial phase (11 distinct, 17 trials)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Asthma
- Bacterial Infections
- Bronchial Spasm
- Bronchiolitis
- Bronchitis
- Conjunctivitis
- Hypersensitivity
- Immune System Diseases
- Infections
- Lung Diseases
- Lung Diseases, Obstructive
- Pneumonia
- Pulmonary Disease, Chronic Obstructive
- Respiratory Sounds
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Seasonal
- Urinary Tract Infections
Recent trials (17)
- NCT04173013CollaboratorN/A—
- NCT05641272Lead sponsorPhase 2/Phase 3Apr 1, 2023
- NCT05400811Lead sponsorPhase 3Dec 31, 2022
- NCT05208060Lead sponsorPhase 1/Phase 2Jun 1, 2022
- NCT04891237Lead sponsorPhase 3Jun 14, 2021
- NCT04898283Lead sponsorPhase 3May 31, 2021
- NCT04874714Lead sponsorPhase 3Apr 30, 2021
- NCT04452643Lead sponsorPhase 3Oct 31, 2020
- NCT04435990Lead sponsorPhase 3Sep 30, 2020
- NCT04363814Lead sponsorPhase 3May 10, 2020
- NCT02527122Lead sponsorN/AJul 21, 2016
- NCT02661854Lead sponsorPhase 2Jun 21, 2016
- NCT02654223Lead sponsorPhase 2Dec 30, 2015
- NCT02543827Lead sponsorPhase 3Nov 1, 2015
- NCT02527187Lead sponsorPhase 2/Phase 3Mar 1, 2014
Details
- Founded
- Madrid, ES Jun 1, 1992
- Last known activity
- Apr 1, 2023